Café

© 2026 Longbridge｜Terms of Service Privacy Policy

LONGBIO-B

01779

----

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

From AI to Biotech: Inside the Fragmented Reality of Hong Kong's Stock Market
Global Report·2 days ago, 04:12 AM
02161-1.00%01779-5.16%
LongBio Pharma Proposes H Share Incentive Plans to Drive Long-Term Growth
Tip Ranks·Jul 15 at 05:37 PM
01779-5.16%
LongBio Pharma proposes H-share option, incentive plans with 10% scheme cap
PUBT·Jul 15 at 05:08 PM
01779-5.16%
LongBio Pharma says FDA clears LP-003 peanut allergy clinical trial application
PUBT·Jul 12 at 07:09 PM
01779-5.16%
The Market's Fringe: From AI Cooling and Global Expansion to Bad Debts
Global Report·Jul 8 at 10:32 PM
03360-0.31%06196-1.12%
Hong Kong Stock Movement: LONGBIO-B fell 10.18%, excess allocation triggered dilution concerns
HK Stock Alerts·Jul 8 at 02:11 AM
01779-5.16%
LongBio Pharma says IPO stabilization period ends after full 2,128,950-share greenshoe exercise at HK$ 96.06
PUBT·Jul 2 at 05:40 AM
01779-5.16%600109-1.51%
Hong Kong Stock Movement: LONGBIO-B plummets 27.97%, concerns over dilution triggered by excess allocation rights
HK Stock Alerts·Jul 2 at 12:11 AM
01779-5.16%
Tianchen Bio-B Plunges 29% in Hong Kong Trading
HK Stock Market Update·Jul 2 at 12:10 AM
01779-5.16%
Tianchen Bio-B plunges 29% to HK$105.80 on no news
HK Stock Market Update·Jul 1 at 09:40 PM
01779-5.16%
Tianchen Bio Surge Follows Positive Allergy Drug Trial Data
HK Stock Market Update·Jun 25 at 09:12 PM
01779-5.16%
Tinchen Bio-HK climbs over 5% on positive allergy drug trial data to set all-time high
HK Stock Market Update·Jun 25 at 12:21 AM
01779-5.16%